Article
Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life
29 Mar 2007
Abstract excerpt
Previously, we described a mouse model where the well-known reproductive carcinogen with estrogenic activity, diethylstilbestrol (DES), caused uterine adenocarcinoma following neonatal treatment. Tumor incidence was dose-dependent reaching >90% by 18 mo following neonatal treatment with 1000 microg/kg/d of DES. These tumors followed the initiation/promotion model of hormonal carcinogenesis with developmental...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
